We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Chinese OTC Drugmaker Warned for Quality Failures, Missing Data
Chinese OTC Drugmaker Warned for Quality Failures, Missing Data
The FDA cited Sunstar for serious violations at a manufacturing facility in China, issuing the firm a warning letter for failing to test incoming drug components and finished products, among other violations.